"Insights from Industry" is a dynamic series of interviews at the cutting edge of the life sciences industry.
Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible
insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
There are two main challenges and both relate to manufacturing. The first one is to make sure you can manufacture therapies with reasonable costs and the second one is to make sure that you can balance the capacity you need with the demands.
This test, which we have branded SelectMDx for Prostate Cancer, came with the acquisition of a company in the Netherlands called NovioGendix. They developed a prototype assay, so they did most of the heavy lifting in terms of discovering the two specific biomarkers that are currently in the product. These biomarkers are tuned towards the detection of what I call clinically significant prostate cancer.
The first thing is, to always remember that we're dealing with a living drug, cells, which are very sensitive to environmental conditions, such as temperature and humidity etc. All of those things can impact on the viability of the drug and its effectiveness.
The pharma and biotech industry continues to struggle to make progress with gender diversity. A recent Credit Suisse report shows that management diversity, as defined by percentage of women in senior management roles, has decreased globally from 18.9 percent in 2014 to 15.5 percent in 2016.
Australia is an acknowledged world leader in the medical technology, biotechnology and pharmaceutical (MTP) sector due to its vibrant ecosystem of start-ups and established companies and thriving research environment.
Organoids are bits of tissue grown in vitro, in a near-physiological 3D setting. The particularity consists in the fact that organoids retain features of the patient they are derived from, even when cultured outside of the human body. This is very different from what traditional, conventional cell culture has been able to do over the past 50 years or so.
In the pharmaceutical industry, there are two main processes - non-sterile and sterile production. Non-sterile production includes tablets, syrups, ointments, and capsules. From a regulatory point of view, the processes can be microbiologically contaminated but within specified microbiological limits.
Solvent removal covers a broad range of Chemical, Biological and Analytical applications where it is necessary to either remove an existing solvent from a solution completely, or to concentrate the solvent to facilitate analysis of a molecule of interest. This could be a single sample or many samples in parallel.
In this interview, Jay Flatley, Executive Chairman of Illumina, gives an introduction to Illumina and the next generation genomics tools they provide.
In this interview Penny Owen, Interim Executive Chair, Life Sciences Hub Wales, describes recent advances in Life Sciences in Wales, and if we are likely to see changes in this due to Brexit.
An interview with Dr. Chase Spurlock, CEO, discussing IQuity's research into IncRNAs and how they are linked to autoimmue diseases.
In this interview, Alison Wake from Genevac, discusses the use of centrifugal concentraters in biological research, and the miVac range provided by Genevac.
In this interview, Dr. Rich Jones introduces bacterial cell counting and an example of when the Multisizer 4e from Beckman Coulter has been used for this application.
An interview with Jean Fallacara, CEO, discussing how Z-SC1 help to ensure safe sample storage at ultra-low temperatures.
In this interview, Dr Harmut Schafer introduces the work being done at the Phenome Center in Birmingham, on metabolic phenotyping using NMR.
An interview with Ian Holland, discussing the differences in microscope cameras and how to determine which one is most suitable for specific pathology applications.
Without testing commercially available honey, it is impossible to guarantee that is safe, natural and authentic. This is because bees are free agents, they cannot be restricted to a specific region, or to a type of plant that you would like them to pollinate.
Microscopy's got a long history. It was developed about 350 years ago for scientists to visualize things they could discern, but not describe. The two pioneers of microscopy were Antoine van Leeuwenhoek, who developed the first microscope and soon after the renowned scientist, Robert Hooke.
There are many grades of spinal cord injuries, in terms of range of movement, from small disabilities to becoming wheelchair bound for the rest of your life, the range is very broad.
Quantity and quality of input samples are two key considerations in successful library preparation for next generation sequencing. The ultimate success or failure of a library preparation is often...